Retatrutide
An investigational peptide-based triple receptor agonist targeting GIP, GLP-1 and glucagon receptors, studied primarily in metabolic and obesity-related clinical research.
Molecular Information
Systems Associated With Retatrutide
Brain & CNS
Human ClinicalTriple GIP, GLP-1 and glucagon receptor agonist investigated in metabolic clinical research.
Gastrointestinal
Human ClinicalTriple GIP, GLP-1 and glucagon receptor agonist investigated in metabolic clinical research.
Liver
Human ClinicalTriple GIP, GLP-1 and glucagon receptor agonist investigated in metabolic clinical research.
Pancreas & Glucose
Human ClinicalTriple GIP, GLP-1 and glucagon receptor agonist investigated in metabolic clinical research.
Metabolic
Human ClinicalTriple GIP, GLP-1 and glucagon receptor agonist investigated in metabolic clinical research.
Adipose Tissue
Human ClinicalTriple GIP, GLP-1 and glucagon receptor agonist investigated in metabolic clinical research.
Endocrine & Hormonal
Human ClinicalTriple GIP, GLP-1 and glucagon receptor agonist investigated in metabolic clinical research.
Regulatory Information
Regulatory status can vary by jurisdiction and may change over time.
Retatrutide Discussions & News
HaxBio provides information for educational and research purposes. Information on this page should not be interpreted as medical advice.